Press releases | WebDisclosure

Basculer en Français

10964	Companies
240006	Keywords
168760	Articles
129121	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 09/11/2024 at 08:00, 2 years ago

EURAZEO AND KURMA PARTNERS INVEST IN THE EUR 93 MILLION FINANCING OF PANTERA TO ESTABLISH COMMERCIAL-SCALE PRODUCTION OF ACTINIUM-225
Eurazeo and Kurma Partners invest EUR 93 million in PanTera for Actinium-225 production to fight cancer, aiming to provide large-scale quantities by 2028 and cover 100,000 patients per year by 2029

EURAZEO Cancer Treatment Actinium-225 Kurma Partners European Healthcare
REGULATED PRESS RELEASE

published on 09/11/2024 at 08:00, 2 years ago

EURAZEO ET KURMA PARTNERS PARTICIPENT A LA LEVEE DE FONDS DE 93 MILLIONS D'EUROS DE PANTERA POUR LA PRODUCTION A ECHELLE COMMERCIALE D'ACTINIUM-225
Eurazeo et Kurma Partners investissent 93 millions d'euros dans PanTera pour produire l'Actinium-225 à grande échelle, renforçant l'offre de soins contre le cancer

EURAZEO Cancer Actinium-225 Kurma Partners PanTera
PRESS RELEASE

published on 09/11/2024 at 08:00, 2 years ago

VERGNET : Nomination de Cédric VERBEKE à la tête de l'activité photovoltaïque
Cédric VERBEKE nommé Responsable commercial et technique photovoltaïque du groupe Vergnet en France pour accélérer le développement de l'activité solaire auprès des entreprises

Énergies Renouvelables Développement Vergnet Photovoltaïque Cédric VERBEKE
PRESS RELEASE

published on 09/11/2024 at 07:45, 2 years ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
PRESS RELEASE

published on 09/11/2024 at 07:30, 2 years ago

Baader Bank and Smartbroker+ strengthen cooperation partnership
Baader Bank renews cooperation agreement with Smartbroker+, enhancing collaboration in account and trading business. Future plans include joint expansion and growth initiatives

Financial Services Growth Baader Bank SMARTBROKER+ Cooperation Partnership
PRESS RELEASE

published on 09/11/2024 at 07:30, 2 years ago

Selfio smoothing the path to funding from the Kreditanstalt für Wiederaufbau (KfW)
Selfio SE, a subsidiary of 3U HOLDING AG, launches a comprehensive KfW funding service to simplify government funding applications for heating systems. More information available on the Selfio website and YouTube channel

3U HOLDING AG Selfio SE KfW Funding Service Government Funding Applications Heating Systems
PRESS RELEASE

published on 09/11/2024 at 07:30, 2 years ago

Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Medincell confie son Contrat de liquidité à ROTHSCHILD MARTIN MAUREL pour animer ses actions sur Euronext Paris, conformément à la réglementation en vigueur

Euronext Paris Contrat De Liquidité Rothschild Martin Maurel Réglementation Medincell
PRESS RELEASE

published on 09/11/2024 at 07:30, 2 years ago

Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Medincell appoints ROTHSCHILD MARTIN MAUREL for liquidity contract management on Euronext Paris, complying with AMF Decision 2021-01

Euronext Paris Liquidity Contract Rothschild Martin Maurel AMF Decision Medincell
PRESS RELEASE

published on 09/11/2024 at 07:14, 2 years ago

Inside Information / News release on accounts, results
Antin Infrastructure Partners reports Half-Year 2024 Results showing growth in AUM, revenue, and EBITDA. Investment activity doubled, with strong financial performance and dividend payout. CEO optimistic about future opportunities

Financial Performance Dividend Payout Investment Activity Antin Infrastructure Partners Half-year 2024 Results
PRESS RELEASE

published on 09/11/2024 at 07:05, 2 years ago

Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU. Positive pivotal data support Dupixent as a new targeted therapy for CSU

Phase 3 Study Dupixent CSU Chronic Spontaneous Urticaria Itch And Hives

Accesswire

Published on 09/11/2026 at 04:00, 5 hours 18 minutes ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 53 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 15 hours 32 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 17 hours 58 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 18 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 09:05, 12 minutes ago

ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 18 minutes ago

Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 18 minutes ago

Picton Property Income Limited - Removal
Published on 09/11/2026 at 09:00, 18 minutes ago

Official List Notice
Published on 09/11/2026 at 09:00, 18 minutes ago

Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market

Les Echos

Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 48 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE